1. Home
  2. GNFT vs ERC Comparison

GNFT vs ERC Comparison

Compare GNFT & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • ERC
  • Stock Information
  • Founded
  • GNFT 1999
  • ERC 2003
  • Country
  • GNFT France
  • ERC United States
  • Employees
  • GNFT 167
  • ERC N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • ERC Finance/Investors Services
  • Sector
  • GNFT Health Care
  • ERC Finance
  • Exchange
  • GNFT Nasdaq
  • ERC Nasdaq
  • Market Cap
  • GNFT 189.6M
  • ERC N/A
  • IPO Year
  • GNFT 2019
  • ERC N/A
  • Fundamental
  • Price
  • GNFT $3.80
  • ERC $8.88
  • Analyst Decision
  • GNFT Strong Buy
  • ERC
  • Analyst Count
  • GNFT 1
  • ERC 0
  • Target Price
  • GNFT $13.00
  • ERC N/A
  • AVG Volume (30 Days)
  • GNFT 9.8K
  • ERC 64.4K
  • Earning Date
  • GNFT 09-19-2024
  • ERC 01-01-0001
  • Dividend Yield
  • GNFT N/A
  • ERC 8.37%
  • EPS Growth
  • GNFT N/A
  • ERC N/A
  • EPS
  • GNFT 0.47
  • ERC 0.72
  • Revenue
  • GNFT $86,225,222.00
  • ERC N/A
  • Revenue This Year
  • GNFT $155.44
  • ERC N/A
  • Revenue Next Year
  • GNFT N/A
  • ERC N/A
  • P/E Ratio
  • GNFT $7.59
  • ERC $12.92
  • Revenue Growth
  • GNFT 175.45
  • ERC N/A
  • 52 Week Low
  • GNFT $3.31
  • ERC $8.51
  • 52 Week High
  • GNFT $6.42
  • ERC $9.74
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 29.24
  • ERC 34.69
  • Support Level
  • GNFT $3.63
  • ERC $9.10
  • Resistance Level
  • GNFT $3.88
  • ERC $9.25
  • Average True Range (ATR)
  • GNFT 0.10
  • ERC 0.08
  • MACD
  • GNFT 0.02
  • ERC -0.03
  • Stochastic Oscillator
  • GNFT 15.30
  • ERC 15.91

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: